- Nuclear medicine is a specialised branch of medical imaging that uses radiopharmaceuticals—radioactive compounds designed to target specific organs, tissues, or metabolic pathways—to visualise physiological processes inside the body. Unlike conventional radiology, which primarily shows anatomical structures, nuclear medicine reveals function, making it indispensable for diagnosing conditions involving metabolism, perfusion, receptor activity, and cellular viability. This functional perspective allows clinicians to detect disease at an earlier stage, often before structural changes become visible. More details on tracer behaviour can be explored through radiopharmaceutical mechanisms.
- Radiopharmaceuticals are administered intravenously, orally, or by inhalation. Once inside the body, they accumulate in target tissues based on biological behaviour—such as glucose uptake, blood flow, or receptor density. As these tracers decay, they emit gamma rays or positrons. External detectors capture this radiation and reconstruct images that show areas of increased or decreased physiological activity. Regions with high tracer uptake appear as “hot spots,” often indicating tumours, inflammation, or hyperfunctioning tissue, while “cold spots” may indicate ischemia, necrosis, or reduced organ activity.
- Two major imaging modalities dominate nuclear medicine: SPECT and PET. SPECT (Single Photon Emission Computed Tomography) uses gamma‑emitting isotopes such as technetium‑99m to produce three‑dimensional functional images. It is widely used in cardiac perfusion studies, bone scans, thyroid imaging, and hepatobiliary assessments. PET (Positron Emission Tomography) uses positron‑emitting tracers such as fluorodeoxyglucose (FDG) to map metabolic activity with high sensitivity. PET‑CT and PET‑MRI combine functional imaging with anatomical detail, making them essential tools in oncology, neurology, and cardiology. More details on these modalities can be explored through SPECT imaging and PET imaging.
- Clinically, nuclear medicine plays a central role in diagnosing and managing a wide range of diseases. In oncology, PET‑CT is used for tumour detection, staging, treatment planning, and monitoring therapeutic response. In cardiology, nuclear perfusion imaging evaluates blood flow to the heart muscle and identifies ischemic regions. Neurological applications include assessing brain metabolism in dementia, epilepsy localisation, and movement disorders. Endocrine studies—such as thyroid scans—help evaluate gland function and detect nodules or cancer. Nuclear medicine also supports renal function assessment, infection imaging, gastrointestinal transit studies, and pulmonary perfusion evaluation.
- Beyond diagnosis, nuclear medicine includes therapeutic applications known as targeted radionuclide therapy. These treatments deliver radiation directly to diseased tissues using biologically targeted radiopharmaceuticals. Radioactive iodine (I‑131) is widely used to treat hyperthyroidism and thyroid cancer. Lutetium‑177‑labelled compounds target neuroendocrine tumours and metastatic prostate cancer. These therapies exploit molecular targeting to deliver lethal radiation doses to cancer cells while sparing surrounding tissues, offering a highly selective and effective treatment option.
- Safety is an important aspect of nuclear medicine. Although radiopharmaceuticals involve exposure to ionising radiation, doses are carefully controlled and generally low. Most tracers have short half‑lives and are rapidly cleared from the body. Patients may receive temporary instructions to minimise radiation exposure to others, especially after therapeutic procedures. Modern imaging systems and radiopharmaceutical design continue to reduce radiation doses while improving diagnostic accuracy.
- Nuclear medicine continues to evolve with advances in detector technology, hybrid imaging, artificial intelligence, and personalised radiopharmaceutical development. These innovations enhance image resolution, improve quantification, and enable more precise targeting of disease processes. As molecular imaging expands, nuclear medicine remains a vital tool for early diagnosis, treatment planning, and monitoring across multiple medical specialties.
